A Glutamate Transporter GLT1, in the Treatment of Bipolar Disorder

NCT00512616 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: Ceftriaxone

Sponsor

National Institute of Mental Health (NIMH)